![July 2023 FDA Watch](https://www.g2intelligence.com/wp-content/uploads/2023/07/July23.LIR_.FDAWatch-iStock-1399931537-1100x800-1-1080x675.jpg)
July 2023 FDA Watch
Key approvals announced in June represented important steps forward for the lab testing industry.
Key approvals announced in June represented important steps forward for the lab testing industry.
The agency recently announced it will decide in December whether to grant clearance for a CRISPR therapy for treating sickle cell disease.
Gather Labs founder and CEO Rachael McCrary discusses how her lab has achieved success beyond COVID-19 testing.
After a significant lull, M&As in the lab diagnostics space heated up in May, with several key deals announced.
On March 27, the agency released a new guidance document to help test developers make the transition to full approval.